(Q39153991)

9 September 2017

title

Fluorescent silver(I) and gold(I)-N-heterocyclic carbene complexes with cytotoxic properties: mechanistic insights (English)

1 reference

9 September 2017

0 references

7

1 reference

9 September 2017

Fabian Mohr

3

0 references

Maria Pia Rigobello

series ordinal

8

object named as

Maria Pia Rigobello

1 reference

9 September 2017

6

Alberto Bindoli

1 reference

9 September 2017

1

Anna Citta

1 reference

9 September 2017

4

Alessandra Folda

1 reference

9 September 2017

Esther Schuh

2

1 reference

9 September 2017

Maria Lina Massimino

series ordinal

5

1 reference

9 September 2017

publication date

1 August 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

5

1 reference

9 September 2017

issue

8

1 reference

9 September 2017

page(s)

1006-1015

1 reference

Next-generation anticancer metallodrugs

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Organometallic anticancer compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Exploring the mechanisms of metal-based pharmacological agents via an integrated approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Visualising gold inside tumour cells following treatment with an antitumour gold(I) complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Dinuclear platinum complexes with N, N'-bis(aminoalkyl)-1,4-diaminoanthraquinones as linking ligands. Part II. Cellular processing in A2780 cisplatin-resistant human ovarian carcinoma cells: new insights into the mechanism of resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Combined arene ruthenium porphyrins as chemotherapeutics and photosensitizers for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

In vitro and in vivo fluorescent imaging of a monofunctional chelated platinum complex excitable using visible light.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

BODIPY-phosphane as a versatile tool for easy access to new metal-based theranostics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Molecular mechanisms and proposed targets for selected anticancer gold compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Gold compounds as therapeutic agents for human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Gold derivatives for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Synthesis and biological studies of some gold(I) complexes containing functionalised alkynes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Metal-NHC complexes: a survey of anti-cancer properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

The medicinal applications of imidazolium carbene-metal complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Anticancer and antimicrobial metallopharmaceutical agents based on palladium, gold, and silver N-heterocyclic carbene complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Cationic, linear Au(I) N-heterocyclic carbene complexes: synthesis, structure and anti-mitochondrial activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Mitochondrial permeability transition induced by dinuclear gold(I)-carbene complexes: potential new antimitochondrial antitumour agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Anticancer therapeutics that target selenoenzymes: synthesis, characterization, in vitro cytotoxicity, and thioredoxin reductase inhibition of a series of gold(I) complexes containing hydrophilic phosphine ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Naphthalimide gold(I) phosphine complexes as anticancer metallodrugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

A gold(I) phosphine complex containing a naphthalimide ligand functions as a TrxR inhibiting antiproliferative agent and angiogenesis inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Anticancer activity of silver-N-heterocyclic carbene complexes: caspase-independent induction of apoptosis via mitochondrial apoptosis-inducing factor (AIF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Synthesis and biological activity of ester- and amide-functionalized imidazolium salts and related water-soluble coinage metal N-heterocyclic carbene complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

OLEX2: a complete structure solution, refinement and analysis program

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Mitochondrial thioredoxin reductase purification, inhibitor studies, and role in cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Noble metal targeting of thioredoxin reductase--covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Differential oxidation of thioredoxin-1, thioredoxin-2, and glutathione by metal ions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Facile Synthesis of Silver(I)−Carbene Complexes. Useful Carbene Transfer Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Ag(I) N-heterocyclic carbene complexes: synthesis, structure, and application

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Treatment of human cancer cells with selenite or tellurite in combination with auranofin enhances cell death due to redox shift

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Structure, mechanism and regulation of peroxiredoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Mitochondrial respiratory chain involvement in peroxiredoxin 3 oxidation by phenethyl isothiocyanate and auranofin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Oxidation of nuclear thioredoxin during oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Metal-based inhibition of poly(ADP-ribose) polymerase--the guardian angel of DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

A gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: implications for anticancer therapeutics targeted to mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Comparative in vitro evaluation of N-heterocyclic carbene gold(I) complexes of the benzimidazolylidene type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MT20260G

21 January 2018

Identifiers

DOI

10.1039/C3MT20260G

1 reference

9 September 2017

1 reference